The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study-Reference-Cited by-同舟云学术

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study

Published:2018-03-26 Issue:10 Volume:20 Page:1393-1399
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Broen Martinus P G¹²,Smits Marion³,Wijnenga Maarten M J²,Dubbink Hendrikus J⁴,Anten Monique H M E¹,Schijns Olaf E M G⁵,Beckervordersandforth Jan⁶,Postma Alida A⁷,van den Bent Martin J²

Affiliation:

1. Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands

2. Department of Neurology, The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands

3. Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands

4. Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands

5. Department of Neurosurgery, Maastricht University Medical Center, Maastricht, Netherlands

6. Department of Pathology, GROW-school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands

7. Department of Radiology, Maastricht University Medical Center, Maastricht, Netherlands

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/10/1393/25679280/noy048.pdf

Reference30 articles.

1. The 2016 World Health Organization Classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol,2016

2. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;Brat;N Engl J Med,2015

3. Molecular neuro-oncology in clinical practice: a new horizon;Weller;Lancet Oncol,2013

4. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups;Weller;Acta Neuropathol,2015

5. Imaging correlates of adult glioma genotypes;Smits;Radiology,2017

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction;American Journal of Neuroradiology;2024-01-18

2. Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted;Neuroradiology;2024-01-15

3. Multi-Level Feature Exploration and Fusion Network for Prediction of IDH Status in Gliomas From MRI;IEEE Journal of Biomedical and Health Informatics;2024-01

4. Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma;Clinical Radiology;2023-12

5. Advances in molecular and imaging biomarkers in lower-grade gliomas;Expert Review of Neurotherapeutics;2023-11-20